Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-03-15
2011-03-15
Kolker, Daniel E (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C435S007920, C435S007950, C530S388100, C530S387100, C530S387300, C424S009100, C424S009340
Reexamination Certificate
active
07906290
ABSTRACT:
An antibody for diagnosis or treatment of neuropsychiatric diseases, in particular schizophrenia, depression or bipolar affective disorders, is characterized in that the antibody recognizes misfolded specific proteins that can be assigned to one of the diseases, and a method for diagnosis by means of antibodies that bind to neuropsychiatric disease-specific proteins.
REFERENCES:
patent: 00/26675 (2000-05-01), None
patent: WO 00/26675 (2000-05-01), None
patent: WO 2005/019828 (2005-03-01), None
Alberts B et al. Molecular Biology of the Cell, Third Edition. 2002. pp. 1216-1220.
Kuby J. Immunology, Third Edition. WH Freeman & Co., New York, 1997. pp. 131-134.
Wall CA et al. Psychiatric manifestations of Creutzfeldt-Jakob disease: A 25-year analysis. J Neuropsychiatry Clin Neurosci. 2005; 17(4):489-95.
Amanda J. Law et al.; The distribution and morphology of prefrontal cortex pyramidal neurons identified using anti-neufilament antibodies SMI32, N200 and FNP7. Normative data and a comparison in subjects schizophrenia, bipolar disorder or major depression; Journal of Psychiatric Research; vol. 37, No. 6, Nov. 6, 2003; pp. 487-499; XP002348495.
Hans-Gert Bernstein et al.; “Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia”; Journal of Neurocytology; vol. 30, No. 8; Aug. 8, 2001; pp. 661-670; XP002348496.
William G. Honer et al.; “Monoclonal antibodies to study the brain in schizophrenia”; Brain Research, vol. 500, No. 1-2; 1989; pp. 379-383; XP00238497.
Einar M. Sigurdsson et al.; “Anti-prion antibodies for prophylaxis following prion exposure in mice”; Neuroscience Letters, Limerick, IE, vol. 336, No. 3; Jan. 23, 2003; pp. 185-187; XP002275536.
Carsten Korth et al.; “Monoclonal Antibodies Specific for the Native, Disease-Associated Isoform of the Prion Protein”; Methods in Enzymology; Academic Press, Inc.; San Diego, CA, US; vol. 309; 1999; pp. 106-122; XP001104847.
Korth Carsten
Leliveld S. Rutger
Ballard Kimberly A.
Kolker Daniel E
Korth Carsten
Rankin , Hill & Clark LLP
LandOfFree
Antibody for diagnosing neuropsychiatric diseases, in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody for diagnosing neuropsychiatric diseases, in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody for diagnosing neuropsychiatric diseases, in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691720